These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 34386076)

  • 1. A standardized extract of cultured
    Islam S; Kitagawa T; Baron B; Kuhara K; Nagayasu H; Kobayashi M; Chiba I; Kuramitsu Y
    Oncol Lett; 2021 Sep; 22(3):654. PubMed ID: 34386076
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Down-regulating Effect of a Standardized Extract of Cultured
    Yamashita SN; Tanaka Y; Kitagawa T; Baron B; Tokuda K; Paudel D; Nakagawa K; Ohta T; Hamada JI; Kobayashi M; Nagayasu H; Kuramitsu Y
    Anticancer Res; 2023 Mar; 43(3):1159-1166. PubMed ID: 36854514
    [TBL] [Abstract][Full Text] [Related]  

  • 3. CUB Domain-containing Protein 1 (CDCP1) Is Down-regulated by Active Hexose-correlated Compound in Human Pancreatic Cancer Cells.
    Kuhara K; Tokuda K; Kitagawa T; Baron B; Tokunaga M; Harada K; Terasaki M; Uehara O; Ohta T; Takai R; Hamada JI; Kobayashi M; Shimo T; Nagayasu H; Kuramitsu Y
    Anticancer Res; 2018 Nov; 38(11):6107-6111. PubMed ID: 30396925
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Active hexose-correlated compound down-regulates HSP27 of pancreatic cancer cells, and helps the cytotoxic effect of gemcitabine.
    Suenaga S; Kuramitsu Y; Kaino S; Maehara S; Maehara Y; Sakaida I; Nakamura K
    Anticancer Res; 2014 Jan; 34(1):141-6. PubMed ID: 24403454
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Active Hexose-correlated Compound Down-regulates Heat Shock Factor 1, a Transcription Factor for HSP27, in Gemcitabine-resistant Human Pancreatic Cancer Cells.
    Tokunaga M; Baron B; Kitagawa T; Tokuda K; Kuramitsu Y
    Anticancer Res; 2015 Nov; 35(11):6063-7. PubMed ID: 26504030
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Active hexose-correlated compound down-regulates sex-determining region Y-box 2 of pancreatic cancer cells.
    Nawata J; Kuramitsu Y; Wang Y; Kitagawa T; Tokuda K; Baron B; Akada J; Suenaga S; Kaino S; Maehara S; Maehara Y; Sakaida I; Nakamura K
    Anticancer Res; 2014 Sep; 34(9):4807-11. PubMed ID: 25202061
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Activation of NF-E2 p45-related factor-2 transcription and inhibition of intestinal tumor development by AHCC, a standardized extract of cultured
    Takahashi M; Fujii G; Hamoya T; Kurokawa Y; Matsuzawa Y; Miki K; Komiya M; Narita T; Mutoh M
    J Clin Biochem Nutr; 2019 Nov; 65(3):203-208. PubMed ID: 31777421
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A Standardized Extract of Cultured
    Kitagawa T; Islam S; Baron B; Tokuda K; Paudel D; Ohta T; Nakagawa K; Kobayashi M; Okada F; Kuramitsu Y
    Anticancer Res; 2023 Mar; 43(3):1239-1244. PubMed ID: 36854525
    [TBL] [Abstract][Full Text] [Related]  

  • 9. AHCC
    Park HJ; Boo S; Park I; Shin MS; Takahashi T; Takanari J; Homma K; Kang I
    Front Immunol; 2022; 13():875872. PubMed ID: 35514996
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The Tumor Growth Inhibitory Effect of a Standardized Extract of Cultured Lentinula edodes Mycelia Using Patient Derived Xenograft Model.
    Yoshii R; Adachi S; Ryo H; Hatanaka E; Yasuda K; Kaji M; Enomoto K; Takanari J; Yoshidome K; Nomura T; Tomiyama N
    Biol Pharm Bull; 2024; 47(2):532-538. PubMed ID: 38417905
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Efficacy of
    Yanagimoto H; Hirooka S; Yamamoto T; Yamaki S; Sekimoto M
    Nutr Cancer; 2023; 75(1):236-246. PubMed ID: 35950537
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Up-regulation of DDX39 in human pancreatic cancer cells with acquired gemcitabine resistance compared to gemcitabine-sensitive parental cells.
    Kuramitsu Y; Suenaga S; Wang Y; Tokuda K; Kitagawa T; Tanaka T; Akada J; Maehara S; Maehara Y; Nakamura K
    Anticancer Res; 2013 Aug; 33(8):3133-6. PubMed ID: 23898070
    [TBL] [Abstract][Full Text] [Related]  

  • 13. High-mobility Group Box 1 and Mitogen-activated Protein Kinase activated Protein Kinase-2 Are Up-regulated in Gemcitabine-resistant Pancreatic Cancer Cells.
    Kuramitsu Y; Wang Y; Kitagawa T; Tokuda K; Akada J; Tokunaga M; Nakamura K
    Anticancer Res; 2015 Jul; 35(7):3861-5. PubMed ID: 26124331
    [TBL] [Abstract][Full Text] [Related]  

  • 14. pTyr421 cortactin is overexpressed in colon cancer and is dephosphorylated by curcumin: involvement of non-receptor type 1 protein tyrosine phosphatase (PTPN1).
    Radhakrishnan VM; Kojs P; Young G; Ramalingam R; Jagadish B; Mash EA; Martinez JD; Ghishan FK; Kiela PR
    PLoS One; 2014; 9(1):e85796. PubMed ID: 24465712
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Oral Supplementation with AHCC
    Singh A; Adam A; Rodriguez L; Peng BH; Wang B; Xie X; Shi PY; Homma K; Wang T
    Pathogens; 2023 Apr; 12(4):. PubMed ID: 37111440
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cortactin and Exo70 mediated invasion of hepatoma carcinoma cells by MMP-9 secretion.
    Zhao G; Zhang H; Huang Z; Lv L; Yan F
    Mol Biol Rep; 2016 May; 43(5):407-14. PubMed ID: 27025610
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Short-hairpin RNA-mediated suppression of cortactin may inhibit the migration and invasion abilities of endometrial cancer cells by reducing lamellipodia.
    Lin H; Fan Y; Zhi Z; Pang L; Sun D
    Iran J Basic Med Sci; 2023; 26(12):1390-1399. PubMed ID: 37970440
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Vascular endothelial growth factor-C upregulates cortactin and promotes metastasis of esophageal squamous cell carcinoma.
    Su CM; Su YH; Chiu CF; Chang YW; Hong CC; Yu YH; Ho YS; Wu CH; Yen CS; Su JL
    Ann Surg Oncol; 2014 Dec; 21 Suppl 4():S767-75. PubMed ID: 25212831
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The Combination of AHCC and ETAS Decreases Migration of Colorectal Cancer Cells, and Reduces the Expression of
    Paganelli F; Chiarini F; Palmieri A; Martinelli M; Sena P; Bertacchini J; Roncucci L; Cappellini A; Martelli AM; Bonucci M; Fiorentini C; Hammarberg Ferri I
    Pharmaceuticals (Basel); 2021 Dec; 14(12):. PubMed ID: 34959725
    [TBL] [Abstract][Full Text] [Related]  

  • 20. miR-182 suppresses invadopodia formation and metastasis in non-small cell lung cancer by targeting cortactin gene.
    Li Y; Zhang H; Gong H; Yuan Y; Li Y; Wang C; Li W; Zhang Z; Liu M; Liu H; Chen J
    J Exp Clin Cancer Res; 2018 Jul; 37(1):141. PubMed ID: 29986736
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.